NO171484C - Anvendelse av sukkeralkohol, polyoksyalkyleneter eller etmonosakkarid eller blandinger derav som baerer for somatostatiner og kalsitoniner for aa oeke biotilgjengeligheten av peptidene ved oral eller rektal tilfoersel - Google Patents

Anvendelse av sukkeralkohol, polyoksyalkyleneter eller etmonosakkarid eller blandinger derav som baerer for somatostatiner og kalsitoniner for aa oeke biotilgjengeligheten av peptidene ved oral eller rektal tilfoersel

Info

Publication number
NO171484C
NO171484C NO872174A NO872174A NO171484C NO 171484 C NO171484 C NO 171484C NO 872174 A NO872174 A NO 872174A NO 872174 A NO872174 A NO 872174A NO 171484 C NO171484 C NO 171484C
Authority
NO
Norway
Prior art keywords
sugarcarcool
somatostatines
polyoxylycylenets
ethmonosaccharide
calcitonines
Prior art date
Application number
NO872174A
Other languages
English (en)
Norwegian (no)
Other versions
NO872174L (no
NO171484B (no
NO872174D0 (no
Inventor
Jacky Vonderscher
Joachim Franz
Michel Steiger
Karl Hornung
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2138/86A external-priority patent/CH667994A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO872174D0 publication Critical patent/NO872174D0/no
Publication of NO872174L publication Critical patent/NO872174L/no
Publication of NO171484B publication Critical patent/NO171484B/no
Publication of NO171484C publication Critical patent/NO171484C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO872174A 1986-05-27 1987-05-25 Anvendelse av sukkeralkohol, polyoksyalkyleneter eller etmonosakkarid eller blandinger derav som baerer for somatostatiner og kalsitoniner for aa oeke biotilgjengeligheten av peptidene ved oral eller rektal tilfoersel NO171484C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH214486 1986-05-27
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.

Publications (4)

Publication Number Publication Date
NO872174D0 NO872174D0 (no) 1987-05-25
NO872174L NO872174L (no) 1987-11-30
NO171484B NO171484B (no) 1992-12-14
NO171484C true NO171484C (no) 1993-03-24

Family

ID=25689611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872174A NO171484C (no) 1986-05-27 1987-05-25 Anvendelse av sukkeralkohol, polyoksyalkyleneter eller etmonosakkarid eller blandinger derav som baerer for somatostatiner og kalsitoniner for aa oeke biotilgjengeligheten av peptidene ved oral eller rektal tilfoersel

Country Status (21)

Country Link
US (1) US5393738A (ko)
KR (1) KR870010870A (ko)
AU (1) AU601740B2 (ko)
BE (1) BE1000722A4 (ko)
CA (1) CA1299495C (ko)
DE (1) DE3716437A1 (ko)
DK (1) DK265587A (ko)
ES (1) ES2008126A6 (ko)
FI (1) FI872313A (ko)
FR (2) FR2599254B1 (ko)
GB (1) GB2190838B (ko)
GR (1) GR870820B (ko)
HU (1) HU198626B (ko)
IL (1) IL82645A0 (ko)
LU (1) LU86901A1 (ko)
MY (1) MY101233A (ko)
NL (1) NL8701143A (ko)
NO (1) NO171484C (ko)
NZ (1) NZ220418A (ko)
SE (1) SE8702188L (ko)
WO (1) WO1987007149A1 (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3845000C2 (de) * 1987-07-10 1998-11-19 Novartis Ag Anwendung von Octreotid zur Behandlung von Brustkrebs
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
FR2668933B1 (fr) * 1990-06-15 1995-05-05 Sandoz Sa Composition pharmaceutique a base de somatostatine.
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
DE19949897A1 (de) * 1999-10-15 2001-04-19 Rainer Rogasch Formkörper und Verfahren zu dessen Herstellung
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
SI1787658T1 (sl) 2005-11-10 2012-07-31 Chemi Spa Formulacije z trajnim sproščanjem somatostatin analognih inhibitorjev rastnega hormona
GB2482810A (en) 2008-09-17 2012-02-15 Chiasma Inc Enhanced delivery of exenatide using a medium chain fatty acid and salt thereof
AU2015201581B2 (en) * 2008-09-17 2017-03-09 Amryt Endo, Inc. Pharmaceutical Compositions and Related Methods of Delivery
WO2011084618A2 (en) 2009-12-16 2011-07-14 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
MA41159A (fr) 2014-12-10 2021-05-12 Chiasma Inc Octréotide destiné à être administré par voie orale en association avec d'autres agents thérapeutiques
ES2975708T3 (es) 2015-01-29 2024-07-12 Novo Nordisk As Comprimidos que comprenden agonista del GLP-1 y recubrimiento entérico
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1062898A (en) * 1912-12-09 1913-05-27 Fred Drew Automobile.
GB1062898A (en) * 1963-06-14 1967-03-22 Evans Medical Ltd Pharmaceutical compositions containing protamines
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
NL167323C (nl) * 1970-09-26 1981-12-16 Organon Nv Werkwijze ter bereiding van een psychofarmacologisch preparaat.
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4041155A (en) * 1974-10-29 1977-08-09 American Home Products Corporation Long acting somatostatin composition
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
NL7607987A (nl) * 1975-08-08 1977-02-10 Merck & Co Inc Werkwijze voor het bereiden van peptiden.
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
US4093574A (en) * 1977-02-02 1978-06-06 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4087390A (en) * 1977-02-02 1978-05-02 Eli Lilly And Company Somatostatin analogs and intermediates thereto
DK144731C (da) * 1976-07-30 1982-10-18 Nordisk Insulinlab Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev
US4230695A (en) * 1976-08-02 1980-10-28 Vitose Corporation Enhanced protein assimilation with fructose
JPS5920647B2 (ja) * 1976-10-01 1984-05-15 武田薬品工業株式会社 注射剤
US4162248A (en) * 1976-10-14 1979-07-24 Merck & Co., Inc. Somatostatin analogs
GB2008403B (en) * 1977-11-04 1982-07-28 Christie R B Parsons J A Pharmaceutical compositions
CA1107273A (en) * 1978-05-19 1981-08-18 Chester A. Meyers Somatostatin analogs having a substituted tryptophyl residue in position eight
CY1327A (en) * 1979-11-27 1986-06-27 Sandoz Ag Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use
JPS56122309A (en) * 1980-03-03 1981-09-25 Teijin Ltd Calcitonin pharmaceutical for rectal administration
JPS57146722A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption
JPS57146723A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption
SE460638B (sv) * 1981-01-14 1989-11-06 Toyo Jozo Kk Suppositoriepreparat med foerbaettrad absorptionsegenskap
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
JPS57118509A (en) * 1981-01-14 1982-07-23 Toyo Jozo Co Ltd Novel preparation of high absorbability
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
JPS58500563A (ja) * 1981-04-27 1983-04-14 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド グルコ−ス、アミノ酸およびインシユリンを含む透析液
EP0083619A1 (en) * 1981-07-17 1983-07-20 Nordisk Insulinlaboratorium A stable aqueous, therapeutic insulin preparation and a process for preparing it
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
DE3482657D1 (de) * 1983-11-21 1990-08-09 Univ Minnesota Gepuffertes polyol-hormones gemisch zur verwendung bei chronischer parenteraler hormonverabreichung.
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides

Also Published As

Publication number Publication date
KR870010870A (ko) 1987-12-18
GB2190838B (en) 1990-12-12
NL8701143A (nl) 1987-12-16
BE1000722A4 (fr) 1989-03-21
ES2008126A6 (es) 1989-07-16
NO872174L (no) 1987-11-30
GB8712193D0 (en) 1987-06-24
NO171484B (no) 1992-12-14
IL82645A0 (en) 1987-11-30
CA1299495C (en) 1992-04-28
FR2630916B1 (fr) 1993-10-22
NZ220418A (en) 1990-07-26
SE8702188D0 (sv) 1987-05-25
AU601740B2 (en) 1990-09-20
DK265587A (da) 1987-11-28
DE3716437A1 (de) 1987-12-03
GB2190838A (en) 1987-12-02
SE8702188L (sv) 1987-11-28
DK265587D0 (da) 1987-05-25
NO872174D0 (no) 1987-05-25
WO1987007149A1 (en) 1987-12-03
FI872313A0 (fi) 1987-05-25
FR2599254B1 (fr) 1989-12-01
FR2599254A1 (fr) 1987-12-04
US5393738A (en) 1995-02-28
AU7336487A (en) 1987-12-03
HU198626B (en) 1989-11-28
FI872313A (fi) 1987-11-28
HUT43956A (en) 1988-01-28
GR870820B (en) 1987-09-25
FR2630916A1 (fr) 1989-11-10
MY101233A (en) 1991-08-17
LU86901A1 (fr) 1987-12-16

Similar Documents

Publication Publication Date Title
FI863965A0 (fi) Foerfarande foer styrning av en anlaeggning saosom dammsugare, centraldammsugare, maskinellt luftkonditioneringssystem eller motsvarande.
FI891348A0 (fi) Foerfarande foer tillverkning av papper eller kartong av aoterfoerbrukade, med entzymer behandlade fibrer.
FI862349A0 (fi) Foerfarande foer observerande av ingredienshalter av gas.
NO171484C (no) Anvendelse av sukkeralkohol, polyoksyalkyleneter eller etmonosakkarid eller blandinger derav som baerer for somatostatiner og kalsitoniner for aa oeke biotilgjengeligheten av peptidene ved oral eller rektal tilfoersel
FI873061A (fi) Foerfarande foer framstaellning av en hydrerings- och/eller dehydreringskatalysator.
NO894011D0 (no) Fremgangsmaate ved oksydering av alkaner.
FI861146A0 (fi) Anordning foer styrning av en trefas inverter som matar vaexelstroemmotorn vid en hiss.
FI865312A0 (fi) Anvaendning av esterfoerening som temporaer mikrobicid.
FI871548A0 (fi) Foerfarande foer framstaellning av vaextfiberbaserade skivor, speciellt av spaonskivor eller fiberskivor.
FI882949A (fi) Foerfarande foer xerografisk tryckning av textilmaterial eller dylikt.
FI860468A (fi) Foerfarande foer torkning av pulverformigt, kornigt, spaonformigt eller motsvarande material.
FI874057A0 (fi) Anvaendning av manganoxidkonkretioner eller manganhaltiga djuphavsmalmer i katalysatorer foer minskning av kvaeveoxider i avgaser.
FI872249A (fi) Foerfarande foer framstaellning av foereningar som inhiberar dopamin- -hydroxylas.
FI864281A0 (fi) Foerfarande foer avlaegsnande av svavelinne- svavelinnehaollet i en uttunnad svaveldioxidhaltig gas.
FI861850A0 (fi) Foerfarande foer rengoering av vaermeoeverfoeringsytor i en aongpanna eller liknande.
FI861144A0 (fi) Foerfarande och anordning foer aostadkommande av referensspaenningar vid en trefas inverter som matar vaexelstroemmotorn vid en hiss.
FI880597A (fi) Foerfarande foer vaermebehandling av vattenhaltiga oljesuspensioner eller liknande.
FI860727A0 (fi) Anordning foer oeverfoering av gasformiga spaoraemneskomponenter fraon en stroemmande gas till stoft eller vaetska.
FI874670A0 (fi) Anordning foer foervaermning eller gloedgning av metalliskt straenggods, i synnerhet traod med groevre tvaersnitt.
FI884390A (fi) Anordning foer begraensning av tryck i gas eller vaetska.
FI854657A (fi) En tuvbildningsanordning som faestes bakom en dragmaskin eller av denna dragen jordberedningsanordning.
FI864195A0 (fi) Foerfarande foer inmatning av gas till vaetska.
FI80865B (fi) Anordning foer dragning eller uppbromsning av metallband eller plaotor.
FI862660A (fi) Anlaeggning foer fyllning av transport- och lagerstaell eller dylikt.
FI862541A (fi) Anordning foer hantering av plaotar eller liknande.